Batistaki Chrysanthi, Graczyk Michal, Janecki Marcin, Lewandowska Agata Anna, Moutinho Rita, Vagdatli Kiriaki
National and Kapodistrian University of Athens, Athens, Greece.
Department of Palliative Care, Faculty of Health Sciences, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.
Drugs Context. 2022 Dec 29;11. doi: 10.7573/dic.2022-9-4. eCollection 2022.
The assessment and treatment of breakthrough cancer pain (BTcP) remain a major challenge in medicine due to its high impact on several aspects of health-related quality of life. BTcP should be carefully monitored in all cancer care settings by a multidisciplinary team to provide an appropriate and personalized clinical approach. The aim of this paper is to provide healthcare professionals involved in cancer pain management with a review of the relevant literature on the relationship between background cancer pain and BTcP which, by definition, occurs despite adequately controlled background cancer pain. The clinical cases presented contribute to a better understanding of this issue and underline its impact in daily clinical practice. This article is part of the Management of breakthrough cancer pain Special Issue: https://www.drugsincontext.com/special_issues/management-of-breakthrough-cancer-pain.
由于突破性癌痛（BTcP）对健康相关生活质量的多个方面具有重大影响，其评估和治疗仍是医学领域的一项重大挑战。在所有癌症护理环境中，多学科团队都应仔细监测BTcP，以提供适当的个性化临床方法。本文旨在为参与癌症疼痛管理的医疗专业人员提供有关背景癌痛与BTcP之间关系的相关文献综述，根据定义，BTcP是在背景癌痛得到充分控制的情况下仍会出现的。所呈现的临床病例有助于更好地理解这一问题，并强调其在日常临床实践中的影响。本文是突破性癌痛管理特刊的一部分：https://www.drugsincontext.com/special_issues/management-of-breakthrough-cancer-pain 。
